CHB

Fund Description
The Global X China Biotech Innovation ETF (CHB) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive China Biotech Innovation Index. The index is designed to track performance of Chinese companies that are active in the fi eld of Biotechnology. Securities must be listed on one of the following stock exchanges: Hong Kong Stock Exchange (HKSE), Shanghai-Hong Kong Stock Connect, Shenzhen-Hong Kong Stock Connect, New York Stock Exchange (NYSE) and NASDAQ. Eligible securities include H-Shares, Red Chips, P-Chips, A-Shares, ADRs and common stocks with a primary listing on the NYSE or NASDAQ. Each security must be classifi ed as Biotechnology by FactSet Industry.
Fund Profile
Fund Name Global X China Biotech Innovation ETF
Fund Exchange Ticker CHB
Fund Sponsor Global X
Fund ISIN US37954Y2515
Net Expense Ratio 0.67 %
Fund Inception Date 22 September 2020
Fund Legal Structure ETF (Open end fund)
Exchange NASDAQ
Listing Country Code US
Fund Investment Objective
ETF Type Specific Global or ExUS Equities - Industry Sector
Asset Class Equities (Stocks)
Index Linked Passive
Index Name Solactive China Biotech Innovation Index
Index Provider Solactive AG
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Emerging Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent Asia
Key Statistics
Return As of Date 23 September 2021
Asset Under Management 5.12 Million (USD)
1 Month Total Return -4.07 %
Year To Date Return -0.03 %
1 Year Total Return
3 Year Annualized Total Return
NAV 16.51
Share Outstanding 310,000
Top 10 Holdings (22 September 2021)
Constituent Name Constituent Ticker Constituent Type Weighting
WALVAX BIOTECHNOLOGY CO-A 300142 EQUI 0.1034700000
BEIGENE LTD-ADR BGNE EQUI 0.1029900000
WUXI BIOLOGICS CAYMAN INC 2269 EQUI 0.1025200000
SHENZHEN KANGTAI BIOLOGICA-A 300601 EQUI 0.0595300000
CHANGCHUN HIGH & NEW TECH-A 000661 EQUI 0.0437900000
PHARMABLOCK SCIENCES NANJI-A 300725 EQUI 0.0433600000
GENSCRIPT BIOTECH CORP 1548 EQUI 0.0424500000
ZHEJIANG WOLWO BIO-PHARMAC-A 300357 EQUI 0.0422500000
SINO BIOPHARMACEUTICAL 1177 EQUI 0.0388400000
BGI GENOMICS CO LTD-A 300676 EQUI 0.0378000000